MEDX ... anybody following? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDX ... anybody following?

MEDX 31.15

-0.3%

Nov 3 1:15 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Icebrg	5/13/2008 10:14:58 AM
	of 2240

The share is on somewhat of a run this morning. I first believed that someone had managed to get a sneaky preview of the ASCO abstracts, but the reason appears to be more mundane - a broker has changed his mind. According to a trusted source posting to the Yahoo board, Briefing came out with the following this morning: Medarex upgraded to Buy at Needham; tgt $11 (7.03 ) Needham upgrades MEDX to Buy from Hold and sets target price at $11 following earnings. The firm believes MEDX stock is positioned to grow from here, based on progress with the internal programs as well as external partnered programs as outlined above. They expect significant newsflow throughout 2008 and into 2009 to generate increasing interest in MEDX stock. They note that Medarex is one-stop shopping in Ab therapeutics, with 6 propriety programs, 4 profit share programs, and over 10 cash and carry programs, in addition to Source: Briefing.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next